Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 8.34% is 31% below its 5-year average of 12.10%, around the middle of its 5-year range (-92.37%–98.51%).
47.79% below its 12-month average of 15.98%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-30): 12.69%.
EBITDA MARGIN
8.34%
EBITDA MARGIN AVG TTM
15.98%
EBITDA MARGIN AVG 3Y
-4.71%
EBITDA MARGIN AVG 5Y
12.10%
EBITDA MARGIN AVG 10Y
56.84%
EBITDA MARGIN AVG 15Y
72.10%
EBITDA MARGIN AVG 20Y
73.13%
CURRENT VS TTM AVG
-47.79%
CURRENT VS 3Y AVG
+277.24%
CURRENT VS 5Y AVG
-31.06%
CURRENT VS 10Y AVG
-85.33%
CURRENT VS 15Y AVG
-88.43%
CURRENT VS 20Y AVG
-88.60%
Caris Life Sciences, Inc.
Market Cap
$8.59B
EBITDA Margin
8.34%
TTM Avg
15.98%
3Y Avg
-4.71%
5Y Avg
12.10%
Market Cap
$8.41B
EBITDA Margin
-3.14%
TTM Avg
-1.08%
3Y Avg
-5.02%
5Y Avg
-19.32%
Market Cap
$8.78B
EBITDA Margin
14.74%
TTM Avg
-8194.33%
3Y Avg
-4134.44%
5Y Avg
-2789.78%
Market Cap
$9.04B
EBITDA Margin
-870.12%
TTM Avg
-705.14%
3Y Avg
-488.60%
5Y Avg
-370.00%
Market Cap
$9.11B
EBITDA Margin
-25.09%
TTM Avg
-47.89%
3Y Avg
-132.36%
5Y Avg
-132.36%
Market Cap
$9.35B
EBITDA Margin
13.28%
TTM Avg
13.13%
3Y Avg
16.37%
5Y Avg
17.13%
Market Cap
$7.80B
EBITDA Margin
-684.44%
TTM Avg
-1767.79%
3Y Avg
-2575.30%
5Y Avg
-1786.18%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Caris Life Sciences, Inc. (CAI) | $8.59B | 8.34% | 15.98% | -4.71% | 12.10% |
| Oscar Health, Inc. (OSCR)vs › | $8.41B | -3.14% | -1.08% | -5.02% | -19.32% |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.78B | 14.74% | -8194.33% | -4134.44% | -2789.78% |
| Kymera Therapeutics, Inc. (KYMR)vs › | $9.04B | -870.12% | -705.14% | -488.60% | -370.00% |
| Axsome Therapeutics, Inc. (AXSM)vs › | $9.11B | -25.09% | -47.89% | -132.36% | -132.36% |
| Bruker Corporation (BRKRP)vs › | $9.35B | 13.28% | 13.13% | 16.37% | 17.13% |
| Cytokinetics, Incorporated (CYTK)vs › | $7.80B | -684.44% | -1767.79% | -2575.30% | -1786.18% |
| Insulet Corp. (PODD)vs › | $9.39B | 21.67% | 20.24% | 16.36% | 15.66% |
| HealthEquity, Inc. (HQY)vs › | $7.65B | 36.33% | 34.52% | 30.06% | 28.41% |
| Hinge Health, Inc. (HNGE)vs › | $7.61B | -92.07% | -49.82% | -47.83% | -47.83% |
Gross Margin
69.7%
EBITDA Margin
8.3%
Operating Margin
5.6%
Net Margin
10.6%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-30 | 12.69% |
| 2026-03-31 | 4.79% |
| 2025-12-31 | 31.65% |
| 2025-09-30 | 17.30% |
| 2025-06-30 | 13.45% |
| 2025-03-31 | -42.10% |
| 2024-12-31 | -21.54% |
| 2024-09-30 | -49.51% |
| 2024-06-30 | 78.58% |
| 2024-03-31 | -92.37% |
| 2021-09-30 | 98.51% |
| 2021-06-30 | 93.72% |
| 2021-03-31 | 95.95% |
| 2020-12-31 | 92.97% |
| 2020-09-30 | 83.70% |
| 2020-06-30 | 81.34% |
| 2020-03-31 | 58.37% |
| 2019-12-31 | 54.76% |
| 2019-09-30 | 59.14% |
| 2019-06-30 | 56.99% |
| 2019-03-31 | 60.78% |
| 2018-12-31 | 61.53% |
| 2018-09-30 | 62.38% |
| 2018-06-30 | 63.56% |
| 2018-03-31 | 64.95% |
| 2017-12-31 | 66.18% |
| 2017-09-30 | 64.93% |
| 2017-06-30 | 61.20% |
| 2017-03-31 | 58.34% |
| 2016-12-31 | 59.13% |
| 2016-09-30 | 52.30% |
| 2016-06-30 | 60.75% |
| 2016-03-31 | 63.28% |
| 2015-12-31 | 70.24% |
| 2015-09-30 | 69.53% |
| 2015-06-30 | 76.65% |
| 2015-03-31 | 76.43% |
| 2014-12-31 | 77.92% |
| 2014-09-30 | 77.88% |
| 2014-06-30 | 76.38% |
| 2014-03-31 | 76.83% |
| 2013-12-31 | 79.67% |
| 2013-09-30 | 79.77% |
| 2013-06-30 | 80.69% |
| 2013-03-31 | 79.68% |
| 2012-12-31 | 81.24% |
| 2012-09-30 | 81.44% |
| 2012-06-30 | 80.43% |
| 2012-03-31 | 85.47% |
| 2011-12-31 | 79.42% |
| 2011-09-30 | 80.98% |
| 2011-06-30 | 76.62% |
| 2011-03-31 | 79.86% |
| 2010-12-31 | 86.07% |
| 2010-09-30 | 79.17% |
| 2010-06-30 | 71.35% |
| 2010-03-31 | 61.48% |
| 2009-12-31 | 66.31% |
| 2009-09-30 | 61.67% |
| 2009-06-30 | 61.26% |
| 2009-03-31 | 66.65% |
| 2008-12-31 | 73.46% |
| 2008-09-30 | 73.20% |
| 2008-06-30 | 76.10% |
| 2008-03-31 | 74.92% |
| 2007-12-31 | 81.01% |
| 2007-09-30 | 77.46% |
| 2007-06-30 | 76.41% |
| 2007-03-31 | 77.03% |
| 2006-09-30 | 78.45% |
| 2006-06-30 | 71.85% |
| 2006-03-31 | 65.63% |
